Arvinas, Inc. (ARVN): Price and Financial Metrics
ARVN Price/Volume Stats
| Current price | $22.69 | 52-week high | $53.08 |
| Prev. close | $21.64 | 52-week low | $20.28 |
| Day low | $21.17 | Volume | 744,000 |
| Day high | $22.71 | Avg. volume | 718,160 |
| 50-day MA | $25.62 | Dividend yield | N/A |
| 200-day MA | $31.51 | Market Cap | 1.56B |
ARVN Stock Price Chart Interactive Chart >
Arvinas, Inc. (ARVN) Company Bio
Arvinas Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, proteolysis targeting chimeras (PROTAC) targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER+ breast cancer. The company is also developing other PROTACs for degrading AR and other clinically relevant AR point mutations; and various other products for the treatment of neurodegenerative diseases, including tauopathies. Arvinas Holding Company, LLC was founded in 2015 and is based in New Haven, Connecticut.
ARVN Price Returns
| 1-mo | -14.60% |
| 3-mo | -13.33% |
| 6-mo | -35.59% |
| 1-year | 5.98% |
| 3-year | -72.46% |
| 5-year | -34.55% |
| YTD | -44.87% |
| 2023 | 20.32% |
| 2022 | -58.35% |
| 2021 | -3.29% |
| 2020 | 106.69% |
| 2019 | 219.77% |
Continue Researching ARVN
Here are a few links from around the web to help you further your research on Arvinas Inc's stock as an investment opportunity:Arvinas Inc (ARVN) Stock Price | Nasdaq
Arvinas Inc (ARVN) Stock Quote, History and News - Yahoo Finance
Arvinas Inc (ARVN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...